• News / Press
  • Contact
Arcutis Logo
Bioscience, applied to the skin
  • Who We Are
    • Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Strategic Collaborations
  • Our Focus
    • Plaque Psoriasis
    • Atopic Dermatitis
    • Eczema
    • Vitiligo
    • Alopecia Areata
  • Pipeline
    • ARQ-151
    • ARQ-250
  • Clinical Trials
  • Investors
Arcutis Logo
bubble image

News / Press

ARQ-151 Plaque Psoriasis Program

Posted on May 7, 2019 by ArqAdmin - Press Releases

ARQ-151-Plaque-Psoriasis-Program
Download

Recent Posts

  • Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis
  • Scott Burrows Joins Arcutis as VP, Finance
  • ARQ-151 Atopic Dermatitis P2a Trial Initiated
  • Arcutis, Inc. to Present at the Jefferies 2019 Global Healthcare Conference
  • John Smither Joins Arcutis as CFO

Archives

  • July 2019
  • June 2019
  • May 2019
  • April 2019

Categories

  • News
  • Press Releases
Arcutis Logo
805.418.5006
information@arcutis.com
  • linkedin
  • Who We Are
  • Our Focus
  • Pipeline
  • Clinical Trials
  • Investors
  • Contact
  • News / Press
  • Legal Disclaimer

© 2019 Arcutis

Designed By Watermark